FIELD: medicine, veterinary science.
SUBSTANCE: invention refers to biotechnology. The vaccine contains an inactivated rabies antigen, a culture medium, a shielding desiccation medium of peptone, sucrose and gelatin, and also an immunity stimulator saponin. The desiccation environment in addition contains aluminium oxide hydrate in the following ratio in an end product (wt %): aluminium oxide hydrate with adsorbed inactivated rabies virus - 6.0-9.0, saponin - 0.75-1.5, peptone - 30.0-33.0, sucrose - 35.0-37,0, gelatin - 9.0-10.0, culture medium - the rest.
EFFECT: dry vaccine exhibits high level of immunogenic activity.
3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING ANTIRABIC VACCINE | 2001 |
|
RU2191600C1 |
ANTIRABIC VACCINE FOR ANIMALS ("УНИРЭВ") | 2008 |
|
RU2366457C1 |
METHOD OF PRODUCTION OF ANTIRABIC VACCINE | 2013 |
|
RU2538617C2 |
ANTIRABIC INACTIVATED EMULSION CULTURE VACCINE FOR PROPHYLACTIC IMMUNIZATION OF DOMESTIC CARNIVORES AND FARM ANIMALS | 2019 |
|
RU2722868C1 |
METHOD OF PREPARING INACTIVATED VACCINE AGAINST RABIES IN ANIMALS | 1997 |
|
RU2134590C1 |
METHOD FOR PREPARING INACTIVATED ANTIRABIC VACCINE IN FRAMELESS CELL GROWTH AND VIRUS REPLICATION IN SHORT-TERM CULTURE CYCLE | 2012 |
|
RU2537183C2 |
METHOD FOR PREPARING ANTIRABIC VACCINE | 2005 |
|
RU2287343C1 |
METHOD FOR PREPARING HIGHLY SPECIFIC HETEROLOGOUS ANTIRABIES SERUM | 2006 |
|
RU2322503C1 |
METHOD FOR OBTAINING HYPERIMMUNE ANTIRABIC SERA | 2001 |
|
RU2196607C2 |
METHOD OF PREPARING ANTIRABIC INACTIVATED CULTURAL VACCINE | 1994 |
|
RU2077338C1 |
Authors
Dates
2010-10-27—Published
2009-05-13—Filed